These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18252968)

  • 1. High-dose, bolus-only, glycoprotein IIb/IIIa inhibitors for elective coronary intervention: logical, safe, cost-effective, and it works!
    Fischell TA
    J Invasive Cardiol; 2008 Feb; 20(2):59-60. PubMed ID: 18252968
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention for ST elevation myocardial infarction.
    Svilaas T; van der Horst IC; Zijlstra F
    Eur Heart J; 2005 Dec; 26(23):2479-81. PubMed ID: 16249222
    [No Abstract]   [Full Text] [Related]  

  • 3. "Bolus-only" glycoprotein IIb/IIIa inhibitor use for elective percutaneous coronary intervention: maybe less is more?
    Fischell TA
    Am Heart J; 2006 Nov; 152(5):812-4. PubMed ID: 17070138
    [No Abstract]   [Full Text] [Related]  

  • 4. Myocardial protection with a beta blocker and glycoprotein IIb/IIIa inhibitor during PCI: attractive concept, but limited evidence of benefit.
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):498-9. PubMed ID: 18819148
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis.
    O'Donoghue M; Antman EM; Braunwald E; Murphy SA; Steg PG; Finkelstein A; Penny WF; Fridrich V; McCabe CH; Sabatine MS; Wiviott SD
    J Am Coll Cardiol; 2009 Aug; 54(8):678-85. PubMed ID: 19679245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of different antiplatelet treatment regimens for primary percutaneous coronary intervention on all-cause mortality.
    Witkowski A; Maciejewski P; Wasek W; Malek LA; Niewada M; Kaminski B; Drzewiecki J; Kosmider M; Kubica J; Ruzyllo W; Peruga JZ; Dudek D; Opolski G; Dobrzycki S; Gil RJ;
    Eur Heart J; 2009 Jul; 30(14):1736-43. PubMed ID: 19376786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current strategies with high-dose tirofiban.
    Mukherjee D; Roffi M
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):275-80. PubMed ID: 17428156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
    Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rescue percutaneous coronary intervention: a review.
    Arora UK; Dhir M
    J Invasive Cardiol; 2005 Nov; 17(11):620-5. PubMed ID: 16264215
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetes and percutaneous coronary intervention: the sweet smell of success?
    Quinn MJ; Moliterno DJ
    Am Heart J; 2003 Feb; 145(2):203-5. PubMed ID: 12595833
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
    Leesar MA
    Catheter Cardiovasc Interv; 2008 Jun; 71(7):907-8. PubMed ID: 18498141
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices.
    Lefebvre CW; Hoekstra JW; Bonaca M; Giugliano R
    J Emerg Med; 2009 Feb; 36(2):162-70. PubMed ID: 18353601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention of thrombotic lesions: still challenging!
    Silva JA
    Catheter Cardiovasc Interv; 2002 May; 56(1):8-9. PubMed ID: 11979523
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M; Borelli G; Gistri R; Ciabatti N; Mazzoni A; Arena M; Petronio AS
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):408-15. PubMed ID: 19360863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased complication rates using the transradial compared to the transfemoral approach in percutaneous coronary intervention in the era of routine stenting and glycoprotein platelet IIb/IIIa inhibitor use: a large single-center experience.
    Eichhöfer J; Horlick E; Ivanov J; Seidelin PH; Ross JR; Ing D; Daly P; Mackie K; Ridley B; Schwartz L; Barolet A; Dzavík V
    Am Heart J; 2008 Nov; 156(5):864-70. PubMed ID: 19061699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myocardial infarction.
    Danchin N; Urban P; De Benedetti E
    Clin Evid; 2003 Dec; (10):37-63. PubMed ID: 15555085
    [No Abstract]   [Full Text] [Related]  

  • 17. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
    Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
    Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycoprotein IIb/IIIa inhibitors and the guidelines for treatment of non-ST-elevation myocardial infarction.
    Coplan NL
    J Am Coll Cardiol; 2004 Mar; 43(5):926-7; author reply 927-8. PubMed ID: 14998642
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use.
    Sabatine MS; Hamdalla HN; Mehta SR; Fox KA; Topol EJ; Steinhubl SR; Cannon CP
    Am Heart J; 2008 May; 155(5):910-7. PubMed ID: 18440341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial infarction.
    Danchin N; Durand E
    Clin Evid; 2006 Jun; (15):140-63. PubMed ID: 16973008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.